Programme (preliminary)

Thursday 22.02.2018
15:00 Welcome
Jürgen Schüttler, Joachim Hornegger (angefragt), Hans-Ulrich Prokosch
Session 1
15:10 The role of big data analytics in the evolution of clinical trials
Lisa McShane
Division of Cancer Treatment & Diagnosis National Institutes of Health, Bethesda, USA
15:45 The use of SNOMED CT in the BMBF MI-I: Opportunities, Challenges and Requirements
Stefan Schulz
Medical University Graz, Graz, Austria
16:20 FHIR – the answer to the interoperability questions of the BMBF MI-I
Kai U. Heitmann
Heitmann Consulting and Services  /  Gefyra GmbH  /  HL7 Deutschland, Köln, Germany
16:55 Coffee Break
Session 2
17:15 The role of neuroimaging in the medical component of the Human Brain Project
Richard Frackowiak
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
17:50 mHealth
Oliver Amft
Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
Friday 23.02.2018
Session 3
 09:00 Results from OHDSI and perspectives for international data sharing projects
George Hripcsak
Biomedical Informatics, Columbia University, New York City, USA
09:35 Problems with exchanging medical data: Experiences in the Netherlands
Arie Hasman
Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands
10:10 Facilitating precision oncology through enterprise-level implementation of next generation sequencing tumor panels
Ahmet Zehir
Memorial Sloan Kettering Cancer Center, New York City, USA
10:45 Coffee Break
Session 4
11:05 The national steering committee (NSC) of the BMBF MI-I, the NSC central office and the NSC working groups
Sebastian Semler
TMF e.V., Berlin, Germany
11:25 Status and activities of the NSC working group „Interoperability“
Thomas Ganslandt
University Hospital Erlangen, Erlangen, Germany
11:45 Status and activities of the NSC working groups „Data Sharing and Consent“
t.b.a.
Session 5
12:05 Components of the MIRACUM Data Integration Centres (DIC) and current status
t.b.a
12:25 Our DIC – what we can do already (exemplary: stroke data evaluation)
Christian Haverkamp
University Hospital Freiburg, Freiburg, Germany
12:35 Our DIC – what we can do already (exemplary: colorectal cancer evaluation)
t.b.a
12:45 Lunch Break
Session 6
13:45 Use Case 1 – Study registries and patient recruitment
Hans-Ulrich Prokosch
Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
14:00 Use Case 2 – Prediction models for Asthma/COPD and brain tumours
t.b.a
14:15 Use Case 3 – precision medicine: example molecular tumour boards (first results and planning)
t.b.a
14:30 Coffee Break
14:50 Bypassing all Trouble: Direct Access to Patients’ Data Treasures
Frank Ückert
DKFZ, Heidelberg, Germany
15:15 MIRACUM master programme across federal borders
Paul Schmücker / Keywan Sohrabi
University of Applied Sciences Mannheim / University of Applied Sciences Mittelhessen, Germany
15:40 Title t.b.a.
Ho-Ryan Chung
Max Planck Institute for Molecular Genetics, Berlin, Germany